Quadrature Capital’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$627K Buy
47,000
+18,129
+63% +$242K 0.01% 510
2025
Q1
$293K Buy
+28,871
New +$293K 0.01% 741